Ceftazidime-avibactam Clinical Trials
2 recruitingDrug
Phase 31Phase 41
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia
Qilu Pharmaceutical Co., Ltd.420 enrolled1 locationNCT07327619
Recruiting
Phase 4
Optimising TREATment for Severe Gram-Negative Bacterial Infections
National University of Singapore600 enrolled41 locationsNCT07004049